Adaptive Biotechnologies Corp SEC filings ADPT
Adaptive Biotechnologies Corp has 832 filings in SEC EDGAR's recent list, going back to Dec 28, 2009. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 4, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2026 | Nov 4, 2026 |
| 10-Q | Quarterly report | Aug 4, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Jul 29, 2026 | Jul 24, 2026 |
| 8-K |
Current report
Material agreement, Agreement ended, New debt, Unregistered share sale, Other events
|
Jun 22, 2026 | Jun 15, 2026 |
| 8-K |
Current report
Other events
|
Jun 15, 2026 | Jun 15, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 9, 2026 | Jun 5, 2026 |
| 10-Q | Quarterly report | May 5, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 5, 2026 | May 5, 2026 |
| ARS | Annual report to shareholders | Apr 24, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 24, 2026 | — |
| DEF 14A | Proxy statement | Apr 24, 2026 | Jun 5, 2026 |
| S-8 | Employee stock plan registration | Feb 27, 2026 | — |
| 10-K | Annual report | Feb 26, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 5, 2026 | Feb 5, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 12, 2026 | Jan 12, 2026 |
| 8-K |
Current report
Other events
|
Dec 30, 2025 | Dec 30, 2025 |
| 10-Q | Quarterly report | Nov 5, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2025 | Nov 5, 2025 |
| 8-K |
Current report
Agreement ended
|
Aug 18, 2025 | Aug 13, 2025 |
| 10-Q | Quarterly report | Aug 5, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2025 | Aug 5, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 12, 2025 | Jun 10, 2025 |
| 10-Q | Quarterly report | May 1, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 1, 2025 | May 1, 2025 |
| ARS | Annual report to shareholders | Apr 29, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 29, 2025 | — |
| DEF 14A | Proxy statement | Apr 29, 2025 | Jun 10, 2025 |
| 10-K | Annual report | Mar 3, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 11, 2025 | Feb 11, 2025 |
| 10-Q | Quarterly report | Nov 7, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2024 | Nov 7, 2024 |
| 10-Q | Quarterly report | Aug 1, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 1, 2024 | Aug 1, 2024 |
| 8-K |
Current report
Shareholder vote results, Other events
|
Jun 11, 2024 | Jun 7, 2024 |
| DEFA14A | Additional proxy material | May 24, 2024 | — |
| 10-Q | Quarterly report | May 7, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 7, 2024 | May 7, 2024 |
| ARS | Annual report to shareholders | Apr 26, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 26, 2024 | — |
| DEF 14A | Proxy statement | Apr 26, 2024 | Jun 7, 2024 |
| 8-K |
Current report
Officer or director change
|
Apr 9, 2024 | Apr 4, 2024 |
| 8-K |
Current report
Results of operations
|
Apr 5, 2024 | Apr 2, 2024 |
| 8-K |
Current report
Officer or director change
|
Apr 2, 2024 | Apr 1, 2024 |
| 10-K | Annual report | Feb 29, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Feb 14, 2024 | Feb 14, 2024 |
| 10-Q | Quarterly report | Nov 9, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2023 | Nov 9, 2023 |
| 8-K |
Current report
Officer or director change
|
Sep 1, 2023 | Sep 1, 2023 |
| 10-Q | Quarterly report | Aug 2, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Aug 2, 2023 | Jul 28, 2023 |
| 8-K |
Current report
Listing notice
|
Jul 3, 2023 | Jun 26, 2023 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 13, 2023 | Jun 9, 2023 |
| DEFA14A | Additional proxy material | Jun 1, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 9, 2023 | May 9, 2023 |
| 10-Q | Quarterly report | May 3, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 3, 2023 | May 3, 2023 |
| ARS | Annual report to shareholders | Apr 28, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Apr 28, 2023 | — |
| DEF 14A | Proxy statement | Apr 28, 2023 | — |
| 8-K |
Current report
Officer or director change
|
Apr 11, 2023 | Apr 7, 2023 |
| S-8 | Employee stock plan registration | Feb 14, 2023 | — |
| 10-K | Annual report | Feb 14, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Feb 14, 2023 | Feb 14, 2023 |
| 10-Q | Quarterly report | Nov 3, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 3, 2022 | Nov 3, 2022 |
| 8-K |
Current report
Material agreement, New debt, Other events
|
Sep 12, 2022 | Sep 12, 2022 |
| 10-Q | Quarterly report | Aug 3, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 3, 2022 | Aug 3, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 14, 2022 | Jun 10, 2022 |
| 10-Q | Quarterly report | May 4, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations
|
May 4, 2022 | May 4, 2022 |
| DEFA14A | Additional proxy material | Apr 22, 2022 | — |
| DEF 14A | Proxy statement | Apr 22, 2022 | Jun 10, 2022 |
| 8-K |
Current report
Other events
|
Mar 25, 2022 | Mar 25, 2022 |
| 8-K |
Current report
Officer or director change
|
Mar 11, 2022 | Mar 9, 2022 |
| 10-K | Annual report | Feb 15, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Feb 15, 2022 | Feb 15, 2022 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Jan 10, 2022 | Jan 4, 2022 |
| 10-Q | Quarterly report | Nov 3, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Nov 3, 2021 | Oct 28, 2021 |
| 10-Q | Quarterly report | Aug 4, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 4, 2021 | Aug 4, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Jun 14, 2021 | Jun 11, 2021 |
| 10-Q | Quarterly report | May 5, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Results of operations
|
May 5, 2021 | May 5, 2021 |
| DEFA14A | Additional proxy material | Apr 23, 2021 | — |
| DEF 14A | Proxy statement | Apr 23, 2021 | Jun 11, 2021 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Mar 17, 2021 | Mar 16, 2021 |
| 8-K |
Current report
Officer or director change
|
Mar 5, 2021 | Mar 4, 2021 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 2, 2021 | Mar 2, 2021 |
| 10-K | Annual report | Feb 24, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Results of operations
|
Feb 24, 2021 | Feb 24, 2021 |
| 8-K |
Current report
Officer or director change
|
Jan 27, 2021 | Jan 21, 2021 |
| 8-K |
Current report
Other events
|
Nov 12, 2020 | Nov 11, 2020 |
| 10-Q | Quarterly report | Nov 10, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2020 | Nov 10, 2020 |
| 8-K |
Current report
Officer or director change
|
Oct 16, 2020 | Oct 9, 2020 |
| 8-K |
Current report
Other events
|
Aug 21, 2020 | Aug 21, 2020 |
| 424B7 | Filing | Aug 21, 2020 | — |
| 10-Q | Quarterly report | Aug 10, 2020 | Jun 30, 2020 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2020 | Aug 10, 2020 |
| 8-K |
Current report
Material agreement, Results of operations, Other events
|
Jul 16, 2020 | Jul 14, 2020 |
| 424B5 | Prospectus supplement | Jul 16, 2020 | — |
| 424B5 | Prospectus supplement | Jul 14, 2020 | — |
| S-3ASR | Automatic shelf registration | Jul 14, 2020 | — |
| 8-K |
Current report
Officer or director change
|
Jun 26, 2020 | Jun 25, 2020 |
| 8-K |
Current report
Shareholder vote results
|
Jun 16, 2020 | Jun 12, 2020 |
| 10-Q | Quarterly report | May 12, 2020 | Mar 31, 2020 |
| 8-K |
Current report
Results of operations
|
May 12, 2020 | May 12, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
May 5, 2020 | May 5, 2020 |
| DEFA14A | Additional proxy material | Apr 24, 2020 | — |
| DEF 14A | Proxy statement | Apr 24, 2020 | Jun 12, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 20, 2020 | Mar 20, 2020 |
| 10-K | Annual report | Feb 26, 2020 | Dec 31, 2019 |
| 8-K |
Current report
Results of operations
|
Feb 26, 2020 | Feb 26, 2020 |
| 8-K |
Current report
Officer or director change
|
Feb 18, 2020 | Feb 13, 2020 |
| 8-K/A | Amended current report | Jan 27, 2020 | Jan 21, 2020 |
| 424B4 | Prospectus | Jan 24, 2020 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 24, 2020 | Jan 21, 2020 |
| EFFECT | Filing | Jan 23, 2020 | — |
| S-1/A | Amended registration statement | Jan 22, 2020 | — |
| CORRESP | Letter to the SEC | Jan 21, 2020 | — |
| CORRESP | Letter to the SEC | Jan 21, 2020 | — |
| S-1 | Registration statement | Jan 21, 2020 | — |
| UPLOAD | Letter from the SEC | Jan 15, 2020 | — |
| DRS | Filing | Jan 9, 2020 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 8, 2020 | Jan 8, 2020 |
| 10-Q | Quarterly report | Nov 12, 2019 | Sep 30, 2019 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2019 | Nov 12, 2019 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Sep 24, 2019 | Sep 24, 2019 |
| 10-Q | Quarterly report | Aug 13, 2019 | Jun 30, 2019 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2019 | Aug 13, 2019 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Aug 7, 2019 | Aug 2, 2019 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 2, 2019 | Jul 31, 2019 |
| S-8 | Employee stock plan registration | Jul 1, 2019 | — |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Jul 1, 2019 | Jun 26, 2019 |
| 424B4 | Prospectus | Jun 27, 2019 | — |
| EFFECT | Filing | Jun 26, 2019 | — |
| CERT | Filing | Jun 26, 2019 | — |
| S-1/A | Amended registration statement | Jun 26, 2019 | — |
| 8-A12B | Filing | Jun 26, 2019 | — |
| CORRESP | Letter to the SEC | Jun 24, 2019 | — |
| CORRESP | Letter to the SEC | Jun 24, 2019 | — |
| S-1/A | Amended registration statement | Jun 19, 2019 | — |
| SEC STAFF LETTER | Filing | Jun 19, 2019 | — |
| CORRESP | Letter to the SEC | Jun 17, 2019 | — |
| S-1/A | Amended registration statement | Jun 17, 2019 | — |
| UPLOAD | Letter from the SEC | Jun 10, 2019 | — |
| CORRESP | Letter to the SEC | Jun 4, 2019 | — |
| CORRESP | Letter to the SEC | May 30, 2019 | — |
| S-1 | Registration statement | May 30, 2019 | — |
| SEC STAFF LETTER | Filing | May 23, 2019 | — |
| UPLOAD | Letter from the SEC | May 23, 2019 | — |
| DRSLTR | Filing | May 8, 2019 | — |
| DRS/A | Filing | May 8, 2019 | — |
| UPLOAD | Letter from the SEC | Apr 25, 2019 | — |
| DRS | Filing | Mar 29, 2019 | — |
| D | Filing | May 11, 2015 | — |
| D | Filing | Jan 22, 2015 | — |
| D | Filing | Jan 21, 2015 | — |
| D/A | Filing | Aug 4, 2014 | — |
| D | Filing | Apr 15, 2014 | — |
| D | Filing | Jul 12, 2013 | — |
| D | Filing | Jun 21, 2012 | — |
| D | Filing | Jun 2, 2011 | — |
| D | Filing | Dec 28, 2009 | — |
Showing 167 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- ADPT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- WA
- Headquarters
- Seattle, WA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1478320
- Former names
- Adaptive TCR Corp (until Jun 2, 2011)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.